Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Carlsson, L
   Drug-induced torsade de pointes: the perspectives of industry
   EUROPEAN HEART JOURNAL SUPPLEMENTS
   
   L. Carlsson, "Drug-induced torsade de pointes: the perspectives of industry", EUR H J SUP, 3(K), 2001, pp. K114-K120
2. Netzer, R; Ebneth, A; Bischoff, U; Pongs, O
   Screening lead compounds for QT interval prolongation
   DRUG DISCOVERY TODAY
   
   R. Netzer et al., "Screening lead compounds for QT interval prolongation", DRUG DISC T, 6(2), 2001, pp. 78-84
3. Yamamoto, K; Tamura, T; Imai, R; Yamamoto, M
   Acute canine model for drug-induced torsades de pointes in drug safety evaluation - Influences of anesthesia and validation with quinidine and astemizole
   TOXICOLOGICAL SCIENCES
   
   K. Yamamoto et al., "Acute canine model for drug-induced torsades de pointes in drug safety evaluation - Influences of anesthesia and validation with quinidine and astemizole", TOXICOL SCI, 60(1), 2001, pp. 165-176
4. Tang, WM; Kang, JS; Wu, XY; Rampe, D; Wang, L; Shen, H; Li, ZY; Dunnington, D; Garyantes, T
   Development and evaluation of high throughput functional assay methods forhERG potassium channel
   JOURNAL OF BIOMOLECULAR SCREENING
   
   W.M. Tang et al., "Development and evaluation of high throughput functional assay methods forhERG potassium channel", J BIOMOL SC, 6(5), 2001, pp. 325-331
5. Horak, F; Stubner, P; Zieglmayer, R; Kavina, A; De Vos, C; Burtin, B; Donnelly, F
   Controlled comparison of the efficacy and safety of cetirizine 10 mg od and fexofenadine 120 mg od in reducing symptoms of seasonal allergic rhinitis
   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
   
   F. Horak et al., "Controlled comparison of the efficacy and safety of cetirizine 10 mg od and fexofenadine 120 mg od in reducing symptoms of seasonal allergic rhinitis", INT A AL IM, 125(1), 2001, pp. 73-79
6. Gungor, S; Onur, F
   Determination of astemizole in pharmaceutical preparations using spectrophotometric methods
   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
   
   S. Gungor e F. Onur, "Determination of astemizole in pharmaceutical preparations using spectrophotometric methods", J PHARM B, 25(3-4), 2001, pp. 511-521
7. Matsumoto, S; Yamazoe, Y
   Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine
   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
   
   S. Matsumoto e Y. Yamazoe, "Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine", BR J CL PH, 51(2), 2001, pp. 133-142
8. Sugiyama, A; Satoh, Y; Hashimoto, K
   Electropharmacologic effects of a new phosphodiesterase III inhibitor, toborinone (OPC-18790), assessed in an in vivo canine model
   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
   
   A. Sugiyama et al., "Electropharmacologic effects of a new phosphodiesterase III inhibitor, toborinone (OPC-18790), assessed in an in vivo canine model", J CARDIO PH, 38(2), 2001, pp. 268-277
9. Ten Eick, AP; Blumer, JL; Reed, MD
   Safety of antihistamines in children
   DRUG SAFETY
   
   A.P. Ten Eick et al., "Safety of antihistamines in children", DRUG SAFETY, 24(2), 2001, pp. 119-147
10. Noguchi, K; Ito, C; Isobe, Y; Fukushima, K; Tanaka, Y; Tanaka, H; Shigenobu, K
    Effects of 5-HT4 receptor agonist prokinetic agents on the action potential parameters of isolated rabbit myocardium
    PHARMACOLOGY
    
    K. Noguchi et al., "Effects of 5-HT4 receptor agonist prokinetic agents on the action potential parameters of isolated rabbit myocardium", PHARMACOL, 62(2), 2001, pp. 73-79
11. Sugiyama, A; Satoh, Y; Hashimoto, K
    Acute electropharmacological effects of intravenously administered amiodarone assessed in the in vivo canine model
    JAPANESE JOURNAL OF PHARMACOLOGY
    
    A. Sugiyama et al., "Acute electropharmacological effects of intravenously administered amiodarone assessed in the in vivo canine model", JPN J PHARM, 87(1), 2001, pp. 74-82
12. Condemi, J; Schulz, R; Lim, J
    Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    
    J. Condemi et al., "Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life", ANN ALLER A, 84(5), 2000, pp. 533-538
13. Monfrecola, G; Masturzo, E; Riccardo, AM; Del Sorbo, A
    Cetirizine for solar urticaria in the visible spectrum
    DERMATOLOGY
    
    G. Monfrecola et al., "Cetirizine for solar urticaria in the visible spectrum", DERMATOLOGY, 200(4), 2000, pp. 334-335
14. Ishikawa, M; Fujita, R; Takayanagi, M; Takayanagi, Y; Sasaki, K
    Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    M. Ishikawa et al., "Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole", BIOL PHAR B, 23(1), 2000, pp. 112-115
15. Pien, LC
    Appropriate use of second generation antihistamines
    CLEVELAND CLINIC JOURNAL OF MEDICINE
    
    L.C. Pien, "Appropriate use of second generation antihistamines", CLEV CLIN J, 67(5), 2000, pp. 372-380
16. Simons, FER
    Prospective, long-term safety evaluation of the H-1-receptor antagonist cetirizine in very young children with atopic dermatitis
    ALLERGOLOGIE
    
    F.E.R. Simons, "Prospective, long-term safety evaluation of the H-1-receptor antagonist cetirizine in very young children with atopic dermatitis", ALLERGOLOGI, 23(5), 2000, pp. 244-255
17. Kosoglou, T; Salfi, M; Lim, JM; Batra, VK; Cayen, MN; Affrime, MB
    Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    T. Kosoglou et al., "Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine", BR J CL PH, 50(6), 2000, pp. 581-589
18. Ramboer, I; Bumbacea, R; Lazarescu, D; Radu, JR
    Cetirizine and loratadine: a comparison using the ED50 in skin reactions
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    I. Ramboer et al., "Cetirizine and loratadine: a comparison using the ED50 in skin reactions", J INT MED R, 28(2), 2000, pp. 69-77
19. Ohmura, T; Nakamura, R; Watanabe, S; Ikeda, Y; Umemura, K; Hashimoto, H
    Comparative electrophysiological effects of the second generation antihistamines, astemizole and ebastine, in a canine myocardial infarction model
    DRUG DEVELOPMENT RESEARCH
    
    T. Ohmura et al., "Comparative electrophysiological effects of the second generation antihistamines, astemizole and ebastine, in a canine myocardial infarction model", DRUG DEV R, 50(2), 2000, pp. 163-169
20. Satoh, Y; Sugiyama, A; Chiba, K; Tamura, T; Hashimoto, K
    QT-prolonging effects of sparfloxacin, a fluoroquinolone antibiotic, assessed in the in vivo canine model with monophasic action potential monitoring
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    Y. Satoh et al., "QT-prolonging effects of sparfloxacin, a fluoroquinolone antibiotic, assessed in the in vivo canine model with monophasic action potential monitoring", J CARDIO PH, 36(4), 2000, pp. 510-515
21. Salmun, LM; Herron, JM; Banfield, C; Padhi, D; Lorber, R; Affrime, MB
    The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years
    CLINICAL THERAPEUTICS
    
    L.M. Salmun et al., "The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years", CLIN THER, 22(5), 2000, pp. 613-621
22. Taglialatela, M; Annunziato, L
    Evaluation of the cardiac safety of second-generation antihistamines
    ALLERGY
    
    M. Taglialatela e L. Annunziato, "Evaluation of the cardiac safety of second-generation antihistamines", ALLERGY, 55, 2000, pp. 22-30
23. Day, JH; Briscoe, MP; Rafeiro, E; Ellis, AK; Pettersson, E; Akerlund, A
    Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure model
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    
    J.H. Day et al., "Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure model", J ALLERG CL, 105(3), 2000, pp. 489-494
24. Satoh, Y; Sugiyama, A; Tamura, K; Hashimoto, K
    Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic actionpotential
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    
    Y. Satoh et al., "Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic actionpotential", JPN CIRC J, 64(6), 2000, pp. 445-451
25. Champeroux, P; Martel, E; Vannier, C; Blanc, V; Leguennec, JY; Fowler, J; Richard, S
    The preclinical assessment of the risk for QT interval prolongation
    THERAPIE
    
    P. Champeroux et al., "The preclinical assessment of the risk for QT interval prolongation", THERAPIE, 55(1), 2000, pp. 101-109
26. Secondo, A; Taglialatela, M; Cataldi, M; Giorgio, G; Valore, M; Di Renzo, G; Annunziato, L
    Pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary GH(3) cells
    MOLECULAR PHARMACOLOGY
    
    A. Secondo et al., "Pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary GH(3) cells", MOLEC PHARM, 58(5), 2000, pp. 1115-1128
27. Tasaka, K
    Epinastine: An update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases
    DRUGS OF TODAY
    
    K. Tasaka, "Epinastine: An update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases", DRUGS TODAY, 36(11), 2000, pp. 735-757
28. Crumb, WJ
    Loratadine blockade of K+ channels in human heart: Comparison with terfenadine under physiological conditions
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    W.J. Crumb, "Loratadine blockade of K+ channels in human heart: Comparison with terfenadine under physiological conditions", J PHARM EXP, 292(1), 2000, pp. 261-264
29. Satoh, Y; Sugiyama, A; Tamura, K; Hashimoto, K
    Effects of mexiletine on the canine cardiovascular system complicating cisapride overdose: Potential utility of mexiletine for the treatment of drug-induced long QT syndrome
    JAPANESE JOURNAL OF PHARMACOLOGY
    
    Y. Satoh et al., "Effects of mexiletine on the canine cardiovascular system complicating cisapride overdose: Potential utility of mexiletine for the treatment of drug-induced long QT syndrome", JPN J PHARM, 83(4), 2000, pp. 327-334
30. Takahara, A; Sugiyama, A; Dohmoto, H; Yoshimoto, R; Hashimoto, K
    Electrophysiological and cardiohemodynamic effects of AH-1058, a new type calcium channel blocker, assessed by the in vivo canine model
    JAPANESE JOURNAL OF PHARMACOLOGY
    
    A. Takahara et al., "Electrophysiological and cardiohemodynamic effects of AH-1058, a new type calcium channel blocker, assessed by the in vivo canine model", JPN J PHARM, 83(2), 2000, pp. 107-112
31. Gilbert, JD; Cahill, SA; McCartney, DG; Lukas, A; Gross, GJ
    Predictors of Torsades de Pointes in rabbit ventricles perfused with sedating and nonsedating histamine H-1-receptor antagonists
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    
    J.D. Gilbert et al., "Predictors of Torsades de Pointes in rabbit ventricles perfused with sedating and nonsedating histamine H-1-receptor antagonists", CAN J PHYSL, 78(5), 2000, pp. 407-414
32. Taglialatela, M; Pannaccione, A; Castaldo, P; Giorgio, G; Annunziato, L
    Inhibition of HERG1 K+ channels by the novel second-generation antihistamine mizolastine
    BRITISH JOURNAL OF PHARMACOLOGY
    
    M. Taglialatela et al., "Inhibition of HERG1 K+ channels by the novel second-generation antihistamine mizolastine", BR J PHARM, 131(6), 2000, pp. 1081-1088
33. Zunkler, BJ; Kuhne, S; Rustenbeck, I; Ott, T
    Mechanism of terfenadine block of ATP-sensitive K+ channels
    BRITISH JOURNAL OF PHARMACOLOGY
    
    B.J. Zunkler et al., "Mechanism of terfenadine block of ATP-sensitive K+ channels", BR J PHARM, 130(7), 2000, pp. 1571-1574
34. Taglialatela, M; Timmerman, H; Annunziato, L
    Cardiotoxic potential and CNS effects of first-generation antihistamines
    TRENDS IN PHARMACOLOGICAL SCIENCES
    
    M. Taglialatela et al., "Cardiotoxic potential and CNS effects of first-generation antihistamines", TRENDS PHAR, 21(2), 2000, pp. 52-56
35. Simons, FER
    H-1-receptor antagonists: safety issues
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    
    F.E.R. Simons, "H-1-receptor antagonists: safety issues", ANN ALLER A, 83(5), 1999, pp. 481-488
36. Rihoux, JP
    Therapeutic index of H-1-antihistamines: example of cetirizine
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    
    J.P. Rihoux, "Therapeutic index of H-1-antihistamines: example of cetirizine", ANN ALLER A, 83(5), 1999, pp. 489-492
37. Sabbah, A; Daele, J; Wade, AG; Ben-Soussen, P; Attali, P
    Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    
    A. Sabbah et al., "Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis", ANN ALLER A, 83(4), 1999, pp. 319-325
38. Barbey, JT; Anderson, M; Ciprandi, G; Frew, AJ; Morad, M; Priori, SG; Ongini, E; Affrime, MB
    Cardiovascular safety of second-generation antihistamines
    AMERICAN JOURNAL OF RHINOLOGY
    
    J.T. Barbey et al., "Cardiovascular safety of second-generation antihistamines", AM J RHINOL, 13(3), 1999, pp. 235-243
39. Fischer, MJE; de Mol, NJ
    Mechanism of action of the nonlipophilic antiallergic drug eclazolast (REV2871) in the inhibition of mediator release in a mast cell model
    INFLAMMATION RESEARCH
    
    M.J.E. Fischer e N.J. de Mol, "Mechanism of action of the nonlipophilic antiallergic drug eclazolast (REV2871) in the inhibition of mediator release in a mast cell model", INFLAMM RES, 48(11), 1999, pp. 569-574
40. Taglialatela, M; Castaldo, P; Pannaccione, A; Giorgio, G; Genovese, A; Marone, G; Annunziato, L
    Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity
    CLINICAL AND EXPERIMENTAL ALLERGY
    
    M. Taglialatela et al., "Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity", CLIN EXP AL, 29, 1999, pp. 182-189
41. Weissenburger, J; Noyer, M; Cheymol, G; Jaillon, P
    Electrophysiological effects of cetirizine, astemizole and D-sotalol in a canine model of long QT syndrome
    CLINICAL AND EXPERIMENTAL ALLERGY
    
    J. Weissenburger et al., "Electrophysiological effects of cetirizine, astemizole and D-sotalol in a canine model of long QT syndrome", CLIN EXP AL, 29, 1999, pp. 190-196
42. Hey, JA; Affrime, M; Cobert, B; Kreutner, W; Cuss, FM
    Cardiovascular profile of loratadine
    CLINICAL AND EXPERIMENTAL ALLERGY
    
    J.A. Hey et al., "Cardiovascular profile of loratadine", CLIN EXP AL, 29, 1999, pp. 197-199
43. Dubertret, L; Aguttes, MM; Tonet, J
    Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR study
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    
    L. Dubertret et al., "Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR study", J EUR A D V, 12(1), 1999, pp. 16-24
44. Affrime, MB; Brannan, MD; Lorber, RR; Danzig, MR; Cuss, F
    A 3-month evaluation of electrocardiographic effects of loratadine in healthy individuals
    ADVANCES IN THERAPY
    
    M.B. Affrime et al., "A 3-month evaluation of electrocardiographic effects of loratadine in healthy individuals", ADV THER, 16(4), 1999, pp. 149-157
45. Bosse, GM; Matyunas, NJ
    Delayed toxidromes
    JOURNAL OF EMERGENCY MEDICINE
    
    G.M. Bosse e N.J. Matyunas, "Delayed toxidromes", J EMERG MED, 17(4), 1999, pp. 679-690
46. Kelani, K; Bebawy, LI; Abdel-Fattah, L
    Determination of astemizole, terfenadine and flunarizine hydrochloride by ternary complex formation with eosin and lead(II)
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    K. Kelani et al., "Determination of astemizole, terfenadine and flunarizine hydrochloride by ternary complex formation with eosin and lead(II)", J PHARM B, 18(6), 1999, pp. 985-992
47. Day, JH; Briscoe, M; Widlitz, MD
    Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmentalexposure unit
    ALLERGOLOGIE
    
    J.H. Day et al., "Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmentalexposure unit", ALLERGOLOGI, 22(5), 1999, pp. 289-300
48. Bayramgurler, D; Bilen, N; Apaydyn, R; Altintas, L; Sal, G; Dokmeci, S; Utkan, T
    Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses
    CLINICAL AND EXPERIMENTAL DERMATOLOGY
    
    D. Bayramgurler et al., "Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses", CLIN EXP D, 24(5), 1999, pp. 407-411
49. de Abajo, FJ; Rodriguez, LAG
    Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    F.J. de Abajo e L.A.G. Rodriguez, "Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs", BR J CL PH, 47(3), 1999, pp. 307-313
50. Battaglia, S; Boldrini, E; Da Settimo, F; Dondio, G; La Motta, C; Marini, AM; Primofiore, G
    Indole amide derivatives: synthesis, structure-activity relationships and molecular modelling studies of a new series of histamine H-1-receptor antagonists
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    
    S. Battaglia et al., "Indole amide derivatives: synthesis, structure-activity relationships and molecular modelling studies of a new series of histamine H-1-receptor antagonists", EUR J MED C, 34(2), 1999, pp. 93-105
51. Wirshing, DA; Wirshing, WC; Kysar, L; Berisford, MA; Goldstein, D; Pashdag, J; Mintz, J; Marder, SR
    Novel antipsychotics: Comparison of weight gain liabilities
    JOURNAL OF CLINICAL PSYCHIATRY
    
    D.A. Wirshing et al., "Novel antipsychotics: Comparison of weight gain liabilities", J CLIN PSY, 60(6), 1999, pp. 358-363
52. Sugiyama, A; Takahara, A; Hashimoto, K
    Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    A. Sugiyama et al., "Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol", J CARDIO PH, 34(1), 1999, pp. 70-77
53. DuBuske, LM
    Second-generation antihistamines: The risk of ventricular arrhythmias
    CLINICAL THERAPEUTICS
    
    L.M. DuBuske, "Second-generation antihistamines: The risk of ventricular arrhythmias", CLIN THER, 21(2), 1999, pp. 281-295
54. Delpon, E; Valenzuela, C; Tamargo, J
    Blockade of cardiac potassium and other channels by antihistamines
    DRUG SAFETY
    
    E. Delpon et al., "Blockade of cardiac potassium and other channels by antihistamines", DRUG SAFETY, 21, 1999, pp. 11-18
55. Gras, J; Llenas, J
    Effects of H-1 antihistamines on animal models of QTc prolongation
    DRUG SAFETY
    
    J. Gras e J. Llenas, "Effects of H-1 antihistamines on animal models of QTc prolongation", DRUG SAFETY, 21, 1999, pp. 39-44
56. Horak, F; Stubner, UP
    Comparative tolerability of second generation antihistamines
    DRUG SAFETY
    
    F. Horak e U.P. Stubner, "Comparative tolerability of second generation antihistamines", DRUG SAFETY, 20(5), 1999, pp. 385-401
57. Grant, JA; Danielson, L; Rihoux, JP; DeVos, C
    A double-blind, single-dose, crossover comparison of cetirizine, ebastine,epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in
    ALLERGY
    
    J.A. Grant et al., "A double-blind, single-dose, crossover comparison of cetirizine, ebastine,epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in", ALLERGY, 54(7), 1999, pp. 700-707
58. Simons, FER
    Prospective, long-term safety evaluation of the H-1-receptor antagonist cetirizine in very young children with atopic dermatitis
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    
    F.E.R. Simons, "Prospective, long-term safety evaluation of the H-1-receptor antagonist cetirizine in very young children with atopic dermatitis", J ALLERG CL, 104(2), 1999, pp. 433-440
59. Persi, L; Demoly, P; Harris, AG; Tisserand, B; Michel, FB; Bousquet, J
    Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    
    L. Persi et al., "Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine", J ALLERG CL, 103(4), 1999, pp. 591-594
60. Pesco-Koplowitz, L; Hassell, A; Lee, P; Zhou, HH; Hall, N; Wiesinger, B; Mechlinski, W; Grover, M; Hunt, T; Smith, R; Travers, S
    Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine
    JOURNAL OF CLINICAL PHARMACOLOGY
    
    L. Pesco-Koplowitz et al., "Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine", J CLIN PHAR, 39(1), 1999, pp. 76-85
61. Rihoux, JP
    Antihistamines H1 drugs: past and present
    THERAPIE
    
    J.P. Rihoux, "Antihistamines H1 drugs: past and present", THERAPIE, 54(5), 1999, pp. 535-539
62. Daabees, HG
    A new sensitive spectrophotometric method for the analysis of some antihistamines
    SPECTROSCOPY LETTERS
    
    H.G. Daabees, "A new sensitive spectrophotometric method for the analysis of some antihistamines", SPECT LETT, 32(6), 1999, pp. 913-930
63. Purohit, A; Duvernelle, C; Melac, M; Benabdesselam, O; Pauli, G; Frossard, N
    Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    
    A. Purohit et al., "Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity", EUR J CL PH, 55(8), 1999, pp. 589-592
64. Khalifa, M; Drolet, B; Daleau, P; Lefez, C; Gilbert, M; Plante, S; O'Hara, GE; Gleeton, O; Hamelin, BA; Turgeon, J
    Block of potassium currents in guinea pig ventricular myocytes and lengthening of cardiac repolarization in man by the histamine H1 receptor antagonist diphenhydramine
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M. Khalifa et al., "Block of potassium currents in guinea pig ventricular myocytes and lengthening of cardiac repolarization in man by the histamine H1 receptor antagonist diphenhydramine", J PHARM EXP, 288(2), 1999, pp. 858-865
65. Satoh, Y; Sugiyama, A; Tamura, K; Hashimoto, K
    Effects of a class III antiarrhythmic drug, dofetilide, on the in situ canine heart assessed by the simultaneous monitoring of hemodynamic and electrophysiological parameters
    JAPANESE JOURNAL OF PHARMACOLOGY
    
    Y. Satoh et al., "Effects of a class III antiarrhythmic drug, dofetilide, on the in situ canine heart assessed by the simultaneous monitoring of hemodynamic and electrophysiological parameters", JPN J PHARM, 81(1), 1999, pp. 79-85
66. Ohmura, T; Chachin, M; Tarui, S; Nagakura, A; Igarashi, T; Ikeda, H; Ikegami, K; Kitagawa, H; Uchida, S
    Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    T. Ohmura et al., "Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys", EUR J PHARM, 378(2), 1999, pp. 169-175
67. Chachin, M; Katayama, Y; Yamada, M; Horio, Y; Ohmura, T; Kitagawa, H; Uchida, S; Kurachi, Y
    Epinastine, a nonsedating histamine H-1 receptor antagonist, has a negligible effect on HERG channel
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    M. Chachin et al., "Epinastine, a nonsedating histamine H-1 receptor antagonist, has a negligible effect on HERG channel", EUR J PHARM, 374(3), 1999, pp. 457-460
68. Crumb, WJ
    Rate-dependent blockade of a potassium current in human atrium by the antihistamine loratadine
    BRITISH JOURNAL OF PHARMACOLOGY
    
    W.J. Crumb, "Rate-dependent blockade of a potassium current in human atrium by the antihistamine loratadine", BR J PHARM, 126(3), 1999, pp. 575-580
69. Karam, H; El Kousy, N; Towakkol, M
    Colorimetric and fluorimetric methods for the determination of some antihistaminics using acid dyes and charge transfer techniques
    ANALYTICAL LETTERS
    
    H. Karam et al., "Colorimetric and fluorimetric methods for the determination of some antihistaminics using acid dyes and charge transfer techniques", ANAL LETTER, 32(1), 1999, pp. 79-96
70. Gates, GA
    Innovar treatment for Meniere's disease
    ACTA OTO-LARYNGOLOGICA
    
    G.A. Gates, "Innovar treatment for Meniere's disease", ACT OTO-LAR, 119(2), 1999, pp. 189-193
71. STEMPEL DA; THOMAS M
    TREATMENT OF ALLERGIC RHINITIS - AN EVIDENCE-BASED EVALUATION OF NASAL CORTICOSTEROIDS VERSUS NONSEDATING ANTIHISTAMINES
    American journal of managed care
    
    D.A. Stempel e M. Thomas, "TREATMENT OF ALLERGIC RHINITIS - AN EVIDENCE-BASED EVALUATION OF NASAL CORTICOSTEROIDS VERSUS NONSEDATING ANTIHISTAMINES", American journal of managed care, 4(1), 1998, pp. 89-96
72. DAVILAJIMENEZ MM; ELIZALDEGONZALEZ MP; GARCIADIAZ S
    STUDY OF HPLC RETENTION BEHAVIOR OF 1-HYDROXY-IMIDAZOLE-3-N-OXIDES, SUBSTITUTED IMIDAZOLES, AND IMIDAZOLE DERIVATIVES USING MOLECULAR AND ADSORPTION PARAMETERS
    Journal of liquid chromatography & related technologies
    
    M.M. Davilajimenez et al., "STUDY OF HPLC RETENTION BEHAVIOR OF 1-HYDROXY-IMIDAZOLE-3-N-OXIDES, SUBSTITUTED IMIDAZOLES, AND IMIDAZOLE DERIVATIVES USING MOLECULAR AND ADSORPTION PARAMETERS", Journal of liquid chromatography & related technologies, 21(11), 1998, pp. 1629-1647
73. MURRISESPIN M; MELAC M; CHARPENTIER JC; DIDIER A
    COMPARISON OF EFFICACY AND SAFETY OF CETIRIZINE AND EBASTINE IN PATIENTS WITH PERENNIAL ALLERGIC RHINITIS
    Annals of allergy, asthma, & immunology
    
    M. Murrisespin et al., "COMPARISON OF EFFICACY AND SAFETY OF CETIRIZINE AND EBASTINE IN PATIENTS WITH PERENNIAL ALLERGIC RHINITIS", Annals of allergy, asthma, & immunology, 80(5), 1998, pp. 399-403
74. FROSSARD N; MELAC M; BENABDESSELAM O; PAULI G
    CONSISTENCY OF THE EFFICACY OF CETIRIZINE AND EBASTINE ON SKIN REACTIVITY
    Annals of allergy, asthma, & immunology
    
    N. Frossard et al., "CONSISTENCY OF THE EFFICACY OF CETIRIZINE AND EBASTINE ON SKIN REACTIVITY", Annals of allergy, asthma, & immunology, 80(1), 1998, pp. 61-65
75. Davis, AS
    The pre-clinical assessment of QT interval prolongation: a comparison of in vitro and in vivo methods
    HUMAN & EXPERIMENTAL TOXICOLOGY
    
    A.S. Davis, "The pre-clinical assessment of QT interval prolongation: a comparison of in vitro and in vivo methods", HUM EXP TOX, 17(12), 1998, pp. 677-680
76. Bousquet, J
    Antihistamines in severe/chronic rhinitis
    CLINICAL AND EXPERIMENTAL ALLERGY
    
    J. Bousquet, "Antihistamines in severe/chronic rhinitis", CLIN EXP AL, 28, 1998, pp. 49-53
77. GONZALEZ MA; ESTES KS
    PHARMACOKINETIC OVERVIEW OF ORAL 2ND-GENERATION H-1 ANTIHISTAMINES
    International journal of clinical pharmacology and therapeutics
    
    M.A. Gonzalez e K.S. Estes, "PHARMACOKINETIC OVERVIEW OF ORAL 2ND-GENERATION H-1 ANTIHISTAMINES", International journal of clinical pharmacology and therapeutics, 36(5), 1998, pp. 292-300
78. KOBAYASHI T; TAKEHANA Y; SHINAGAWA K; TSUYUKI S; TOKUTAKE Y; SATO M; MOMOSE D
    PHARMACOLOGICAL CHARACTERIZATION OF A NOVEL LONG-ACTING HISTAMINE H-1RECEPTOR ANTAGONIST, KAA-276
    Biological & pharmaceutical bulletin
    
    T. Kobayashi et al., "PHARMACOLOGICAL CHARACTERIZATION OF A NOVEL LONG-ACTING HISTAMINE H-1RECEPTOR ANTAGONIST, KAA-276", Biological & pharmaceutical bulletin, 21(4), 1998, pp. 350-355
79. Hagihara, A; Sugiyama, A; Hashimoto, K
    Effects of antiarrhythmic drugs on the monophasic action potential of the canine isolated, blood-perfused ventricular septum preparation
    HEART AND VESSELS
    
    A. Hagihara et al., "Effects of antiarrhythmic drugs on the monophasic action potential of the canine isolated, blood-perfused ventricular septum preparation", HEART VESS, 13(4), 1998, pp. 181-188
80. WROBLEWSKI BA
    ANTIHISTAMINES
    The journal of head trauma rehabilitation
    
    B.A. Wroblewski, "ANTIHISTAMINES", The journal of head trauma rehabilitation, 13(1), 1998, pp. 83-85
81. ADAMANTIDIS MM; DUMOTIER BM; CARON JF; BORDET R
    SPARFLOXACIN BUT NOT LEVOFLOXACIN OR OFLOXACIN PROLONGS CARDIAC REPOLARIZATION IN RABBIT PURKINJE-FIBERS
    Fundamental and clinical pharmacology
    
    M.M. Adamantidis et al., "SPARFLOXACIN BUT NOT LEVOFLOXACIN OR OFLOXACIN PROLONGS CARDIAC REPOLARIZATION IN RABBIT PURKINJE-FIBERS", Fundamental and clinical pharmacology, 12(1), 1998, pp. 70-76
82. Pan, JB; O'Neill, AB; Hancock, AA; Sullivan, PP; Brioni, JD
    Histaminergic ligands attenuate barrel rotation in rats following unilateral labyrinthectomy
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    
    J.B. Pan et al., "Histaminergic ligands attenuate barrel rotation in rats following unilateral labyrinthectomy", METH FIND E, 20(9), 1998, pp. 771-777
83. Rankin, AC
    Cardiac adverse effects of H-1-antihistamines
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    
    A.C. Rankin, "Cardiac adverse effects of H-1-antihistamines", REV FR ALLE, 38(10), 1998, pp. 931-934
84. ABUSHAREEAH AM; YOUSSUF M; DECKERS I; DEMAHIEU C
    DOUBLE-BLIND, PARALLEL, RANDOMIZED PILOT-STUDY COMPARING THE EFFICACYAND TOLERANCE OF CETIRIZINE 10 MG, MEQUITAZINE 2X5 MG AND PLACEBO IN THE TREATMENT OF PATIENTS SUFFERING FROM CHRONIC URTICARIA - COMPARISON OF SUPPRESSIVE EFFECTS ON HISTAMINE-INDUCED WEALS AND FLARES
    Drug development research
    
    A.M. Abushareeah et al., "DOUBLE-BLIND, PARALLEL, RANDOMIZED PILOT-STUDY COMPARING THE EFFICACYAND TOLERANCE OF CETIRIZINE 10 MG, MEQUITAZINE 2X5 MG AND PLACEBO IN THE TREATMENT OF PATIENTS SUFFERING FROM CHRONIC URTICARIA - COMPARISON OF SUPPRESSIVE EFFECTS ON HISTAMINE-INDUCED WEALS AND FLARES", Drug development research, 43(4), 1998, pp. 185-192
85. WANG WX; EBERT SN; LIU XK; CHEN YW; DRICI MD; WOOSLEY RL
    CONVENTIONAL ANTIHISTAMINES SLOW CARDIAC REPOLARIZATION IN ISOLATED-PERFUSED (LANGENDORFF) FELINE HEARTS
    Journal of cardiovascular pharmacology
    
    W.X. Wang et al., "CONVENTIONAL ANTIHISTAMINES SLOW CARDIAC REPOLARIZATION IN ISOLATED-PERFUSED (LANGENDORFF) FELINE HEARTS", Journal of cardiovascular pharmacology, 32(1), 1998, pp. 123-128
86. HASHIMOTO H; NISHIMOTO M; OHMURA T; WATANABE S; IKEDA Y; NAKAMURA R; UMEMURA K; NAKASHIMA M
    EFFECTS OF ASTEMIZOLE ON VENTRICULAR ACTIVATION, EFFECTIVE REFRACTORYPERIODS, RT INTERVALS, AND PROGRAMMED STIMULATION-INDUCED VENTRICULARARRHYTHMIAS IN DOG HEARTS WITH MYOCARDIAL-INFARCTION
    Journal of cardiovascular pharmacology
    
    H. Hashimoto et al., "EFFECTS OF ASTEMIZOLE ON VENTRICULAR ACTIVATION, EFFECTIVE REFRACTORYPERIODS, RT INTERVALS, AND PROGRAMMED STIMULATION-INDUCED VENTRICULARARRHYTHMIAS IN DOG HEARTS WITH MYOCARDIAL-INFARCTION", Journal of cardiovascular pharmacology, 31(2), 1998, pp. 286-291
87. HORAK F; TOTH J; MARKS B; STUBNER UP; BERGER UE; JAGER S; BURTIN B; DUBY C
    EFFICACY AND SAFETY RELATIVE TO PLACEBO OF AN ORAL FORMULATION OF CETIRIZINE AND SUSTAINED-RELEASE PSEUDOEPHEDRINE IN THE MANAGEMENT OF NASAL CONGESTION
    Allergy
    
    F. Horak et al., "EFFICACY AND SAFETY RELATIVE TO PLACEBO OF AN ORAL FORMULATION OF CETIRIZINE AND SUSTAINED-RELEASE PSEUDOEPHEDRINE IN THE MANAGEMENT OF NASAL CONGESTION", Allergy, 53(9), 1998, pp. 849-856
88. BOUSQUET J; CZARLEWSKI W; COUGNARD J; DANZIG M; MICHEL FB
    CHANGES IN SKIN-TEST REACTIVITY DO NOT CORRELATE WITH CLINICAL EFFICACY OF H-1-BLOCKERS IN SEASONAL ALLERGIC RHINITIS
    Allergy
    
    J. Bousquet et al., "CHANGES IN SKIN-TEST REACTIVITY DO NOT CORRELATE WITH CLINICAL EFFICACY OF H-1-BLOCKERS IN SEASONAL ALLERGIC RHINITIS", Allergy, 53(6), 1998, pp. 579-585
89. RATNER PH; VANBAVEL JH; MARTIN BG; HAMPEL FC; HOWLAND WC; ROGENES PR; WESTLUND RE; BOWERS BW; COOK CK
    A COMPARISON OF THE EFFICACY OF FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY AND LORATADINE, ALONE AND IN COMBINATION, FOR THE TREATMENT OF SEASONAL ALLERGIC RHINITIS
    Journal of family practice
    
    P.H. Ratner et al., "A COMPARISON OF THE EFFICACY OF FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY AND LORATADINE, ALONE AND IN COMBINATION, FOR THE TREATMENT OF SEASONAL ALLERGIC RHINITIS", Journal of family practice, 47(2), 1998, pp. 118-125
90. DAY JH; BRISCOE M; WIDLITZ MD
    CETIRIZINE, IORATADINE, OR PLACEBO IN SUBJECTS WITH SEASONAL ALLERGICRHINITIS - EFFECTS AFTER CONTROLLED RAGWEED POLLEN CHALLENGE IN AN ENVIRONMENTAL EXPOSURE UNIT
    Journal of allergy and clinical immunology
    
    J.H. Day et al., "CETIRIZINE, IORATADINE, OR PLACEBO IN SUBJECTS WITH SEASONAL ALLERGICRHINITIS - EFFECTS AFTER CONTROLLED RAGWEED POLLEN CHALLENGE IN AN ENVIRONMENTAL EXPOSURE UNIT", Journal of allergy and clinical immunology, 101(5), 1998, pp. 638-645
91. DRUCE HM; THODEN WR; MURE P; FUREY SA; LOCKHART EA; XIE TL; GALANT S; PRENNER BM; WEINSTEIN S; ZIERING R; BRANDON ML
    BROMPHENIRAMINE, LORATADINE, AND PLACEBO IN ALLERGIC RHINITIS - A PLACEBO-CONTROLLED COMPARATIVE CLINICAL-TRIAL
    Journal of clinical pharmacology
    
    H.M. Druce et al., "BROMPHENIRAMINE, LORATADINE, AND PLACEBO IN ALLERGIC RHINITIS - A PLACEBO-CONTROLLED COMPARATIVE CLINICAL-TRIAL", Journal of clinical pharmacology, 38(4), 1998, pp. 382-389
92. IKEDA S; OKA H; MATUNAGA K; KUBO S; ASAI S; MIYAHARA Y; OSAKA A; KOHNO S
    ASTEMIZOLE-INDUCED TORSADES-DE-POINTES IN A PATIENT WITH VASOSPASTIC ANGINA
    Japanese Circulation Journal
    
    S. Ikeda et al., "ASTEMIZOLE-INDUCED TORSADES-DE-POINTES IN A PATIENT WITH VASOSPASTIC ANGINA", Japanese Circulation Journal, 62(3), 1998, pp. 225-227
93. SASTRY CSP; NAIDU PY
    SPECTROPHOTOMETRIC DETERMINATION OF ASTEMIZOLE
    Talanta
    
    C.S.P. Sastry e P.Y. Naidu, "SPECTROPHOTOMETRIC DETERMINATION OF ASTEMIZOLE", Talanta, 45(5), 1998, pp. 795-799
94. TAGLIALATELA M; PANNACCIONE A; CASTALDO P; GIORGIO G; ZHOU ZF; JANUARY CT; GENOVESE A; MARONE G; ANNUNZIATO L
    MOLECULAR-BASIS FOR THE LACK OF HERG K-RELATED CARDIOTOXICITY BY THE H-1 RECEPTOR BLOCKER CETIRIZINE COMPARED WITH OTHER 2ND-GENERATION ANTIHISTAMINES( CHANNEL BLOCK)
    Molecular pharmacology
    
    M. Taglialatela et al., "MOLECULAR-BASIS FOR THE LACK OF HERG K-RELATED CARDIOTOXICITY BY THE H-1 RECEPTOR BLOCKER CETIRIZINE COMPARED WITH OTHER 2ND-GENERATION ANTIHISTAMINES( CHANNEL BLOCK)", Molecular pharmacology, 54(1), 1998, pp. 113-121
95. MATSUNAGA K; SATO T; SHUTO H; TSURUTA Y; SUEMARU K; GOMITA Y; OISHI R
    INHIBITION OF NEURONAL DOPAMINE UPTAKE BY SOME ANTIALLERGIC DRUGS
    European journal of pharmacology
    
    K. Matsunaga et al., "INHIBITION OF NEURONAL DOPAMINE UPTAKE BY SOME ANTIALLERGIC DRUGS", European journal of pharmacology, 350(2-3), 1998, pp. 165-169
96. FISCHER MJE; PAULUSSEN JJC; TOLLENAERE JP; DEMOL NJ; JANSSEN LHM
    STRUCTURE-ACTIVITY-RELATIONSHIPS OF ASTEMIZOLE DERIVATIVES FOR INHIBITION OF STORE OPERATED CA2+ CHANNELS AND EXOCYTOSIS
    European journal of pharmacology
    
    M.J.E. Fischer et al., "STRUCTURE-ACTIVITY-RELATIONSHIPS OF ASTEMIZOLE DERIVATIVES FOR INHIBITION OF STORE OPERATED CA2+ CHANNELS AND EXOCYTOSIS", European journal of pharmacology, 350(2-3), 1998, pp. 353-361
97. MENARDO JL; WESSEL F; COUGNARD J; CZARLEWSKI W
    PROPHYLACTIC TREATMENT WITH LORATADINE VERSUS CROMOLYN SODIUM IN CHILDREN WITH MILD-TO-MODERATE PERENNIAL ALLERGIC-ASTHMA
    Current therapeutic research
    
    J.L. Menardo et al., "PROPHYLACTIC TREATMENT WITH LORATADINE VERSUS CROMOLYN SODIUM IN CHILDREN WITH MILD-TO-MODERATE PERENNIAL ALLERGIC-ASTHMA", Current therapeutic research, 59(8), 1998, pp. 567-578
98. FISCHER MJE; PAULUSSEN JJC; DEMOL NJ; JANSSEN LHM
    DUAL EFFECT OF THE ANTIALLERGIC ASTEMIZOLE ON CA2-2H3) CELLS - RELEASE OF CA2+ FROM INTRACELLULAR STORES AND INHIBITION OF CA2+ RELEASE-ACTIVATED CA2+ INFLUX( FLUXES IN RAT BASOPHILIC LEUKEMIA (RBL)
    Biochemical pharmacology
    
    M.J.E. Fischer et al., "DUAL EFFECT OF THE ANTIALLERGIC ASTEMIZOLE ON CA2-2H3) CELLS - RELEASE OF CA2+ FROM INTRACELLULAR STORES AND INHIBITION OF CA2+ RELEASE-ACTIVATED CA2+ INFLUX( FLUXES IN RAT BASOPHILIC LEUKEMIA (RBL)", Biochemical pharmacology, 55(8), 1998, pp. 1255-1262
99. KOBAYASHI T; TAKEHANA Y; SHINAGAWA K; TSUYUKI S; TOKUTAKE Y; SATO M; MOMOSE D
    EFFECTS OF INHALED KAA-276, A SELECTIVE HISTAMINE H-1 RECEPTOR ANTAGONIST, ON ANTIGEN-INDUCED AND HISTAMINE-INDUCED BRONCHOCONSTRICTION IN ANIMALS
    Arzneimittel-Forschung
    
    T. Kobayashi et al., "EFFECTS OF INHALED KAA-276, A SELECTIVE HISTAMINE H-1 RECEPTOR ANTAGONIST, ON ANTIGEN-INDUCED AND HISTAMINE-INDUCED BRONCHOCONSTRICTION IN ANIMALS", Arzneimittel-Forschung, 48(8), 1998, pp. 826-831
100. GAWCHIK SM; LIM J
     COMPARISON OF INTRANASAL TRIAMCINOLONE ACETONIDE WITH ORAL LORATADINEIN THE TREATMENT OF SEASONAL RAGWEED-INDUCED ALLERGIC RHINITIS
     American journal of managed care
     
     S.M. Gawchik e J. Lim, "COMPARISON OF INTRANASAL TRIAMCINOLONE ACETONIDE WITH ORAL LORATADINEIN THE TREATMENT OF SEASONAL RAGWEED-INDUCED ALLERGIC RHINITIS", American journal of managed care, 3(7), 1997, pp. 1052-1058